Ophthalmology Times

New tried-and-true treatments for retinal vein occlusion

More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...
Daily Journal

Idaho will begin using deep veins as backup for lethal injection executions, officials say

BOISE, Idaho (AP) — Idaho will begin using central veins deep in the groin, neck, chest or arm for executions by lethal injection if attempts to insert standard IV lines fail, the Idaho Department of ...
Seeking Alpha

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...
Nasdaq

EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting

EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed every 4 ...